(Q39704080)

English

Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the Kyushu and Okinawa Population Study (KOPS).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the Kyushu and Okinawa Population Study (KOPS). (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

author name string

N Furusyo

1

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

T Koga

2

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

M Ai

3

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

S Otokozawa

4

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

T Kohzuma

5

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

H Ikezaki

6

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

E J Schaefer

7

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

J Hayashi

8

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

publication date

27 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

54

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

3028-3036

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2310-6

21 January 2018

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2310-6

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2310-6

21 January 2018

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2310-6

21 January 2018

International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2310-6

21 January 2018

Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2310-6

21 January 2018

Comparison of glycated albumin (GA) and glycated hemoglobin (HbA1c) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2310-6

21 January 2018

Glycated albumin and direct low density lipoprotein cholesterol levels in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2310-6

21 January 2018

An enzymatic method for the measurement of glycated albumin in biological samples

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2310-6

21 January 2018

Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2310-6

21 January 2018

Relationship between clinical markers of glycemia and glucose excursion evaluated by continuous glucose monitoring (CGM).

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2310-6

21 January 2018

Risk factors for and the prevalence of peripheral arterial disease and its relationship to carotid atherosclerosis: the Kyushu and Okinawa Population Study (KOPS).

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2310-6

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2310-6

21 January 2018

Statistical methods for monitoring the relationship between the IFCC reference measurement procedure for hemoglobin A1c and the designated comparison methods in the United States, Japan, and Sweden

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2310-6

21 January 2018

Determining Stability of Stored Samples Retrospectively: The Validation of Glycated Albumin

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2310-6

21 January 2018

Comparison of fasting and postprandial plasma lipoproteins in subjects with and without coronary heart disease

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2310-6

21 January 2018

Body mass index negatively influences glycated albumin, but not glycated hemoglobin, in diabetic patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2310-6

21 January 2018

Analysis of the method for conversion between levels of HbA1c and glycated albumin by linear regression analysis using a measurement error model

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2310-6

21 January 2018

Nontraditional markers of glycemia: associations with microvascular conditions

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2310-6

21 January 2018

Racial differences in glycemic markers: a cross-sectional analysis of community-based data

1 reference

https://api.crossref.org/works/10.1007%2FS00125-011-2310-6

21 January 2018

Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe

1 reference

https://pubmed.ncbi.nlm.nih.gov/21947435

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/21947435

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes: Diabetes Care 2009; 32(7): 1327-1334.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21947435

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The case for blood glucose control

1 reference

https://pubmed.ncbi.nlm.nih.gov/21947435

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between assays of glycemia in diabetic subjects with advanced chronic kidney disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/21947435

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of hemoglobin variants (Hb J, Hb G, and Hb E) on HbA1c values as measured by cation-exchange HPLC (Diamat)

1 reference

https://pubmed.ncbi.nlm.nih.gov/21947435

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of serum levels of glycated albumin, C-reactive protein and tumor necrosis factor-alpha with the severity of coronary artery disease and renal impairment in patients with type 2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/21947435

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-011-2310-6

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

release_rbkf553zwzadrpinwb3x7myc24

1 reference

https://api.fatcat.wiki/v0/release/rbkf553zwzadrpinwb3x7myc24

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39704080&oldid=2203109265"